News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Patients With Diabetes and Chronic Kidney Disease: ACE Inhibitor or ARB Treatment, Medical Costs for Disease Management, and the FINE-CKD Model to Evaluate Economic Value of Finerenone

Patients With Diabetes and Chronic Kidney Disease: ACE Inhibitor or ARB Treatment, Medical Costs for Disease Management, and the FINE-CKD Model to Evaluate Economic Value of Finerenone - Participating Faculty

By

December 8th 2021

ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease

ByLinda F. Fried, MD, MPH,Natalia Petruski-Ivleva, PhD,Kerstin Folkerts, MSc,Niklas Schmedt, DrPH,Priscilla Velentgas, PhD,Csaba P. Kovesdy, MD

December 8th 2021

Medical Costs for Managing Chronic Kidney Disease and Related Complications in Patients With Chronic Kidney Disease and Type 2 Diabetes

ByKeith A. Betts, PhD,Jinlin Song, PhD,Elizabeth Faust, MBA, MPH,Karen Yang, BA,Yuxian Du, PhD,Sheldon X. Kong, PhD,Rakesh Singh, PhD

December 8th 2021

FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes

ByMichał Pochopień, MSc,David Z. I. Cherney, MD, PhD,Kerstin Folkerts, MSc,Pierre Levy, PhD,Aurélie Millier, PhD,Stephen Morris, PhD,Prabir Roy-Chaudhury, MD, PhD,Sean D. Sullivan, PhD,Paul Mernagh, MCom

December 8th 2021

eAppendix: ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease

ByLinda F. Fried, MD, MPH,Natalia Petruski-Ivleva, PhD,Kerstin Folkerts, MSc,Niklas Schmedt, DrPH,Priscilla Velentgas, PhD,Csaba P. Kovesdy, MD

December 8th 2021

eAppendix: FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes

ByMichał Pochopień, MSc,David Z. I. Cherney, MD, PhD,Kerstin Folkerts, MSc,Pierre Levy, PhD,Aurélie Millier, PhD,Stephen Morris, PhD,Prabir Roy-Chaudhury, MD, PhD,Sean D. Sullivan, PhD,Paul Mernagh, MCom

December 8th 2021

Trending on AJMC

House Republicans Block Vote on ACA Subsidy Extension

5 Things to Know as Flu Season Begins

Study Suggests Adding BTKi to Chemo May Improve Early Outcomes in Richter Transformation in CLL

Zasocitinib Hits Phase 3 End Points in Plaque Psoriasis

FDA Approval of Subcutaneous Amivantamab Offers Faster, Safer Option for EGFR-Mutated NSCLC

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.